Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Karyopharm Therapeutics Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 11 months agokaryopharm.com
Karyopharm Therapeutics Inc., a leading biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for cancer and other serious diseases. Founded in 2010, Karyopharm has made significant strides in the industry, particularly with its flagship product, XPOVIO (selinexor), which targets the nuclear export protein XPO1 to enhance cancer treatment efficacy.
With a strong presence in the oncology sector, Karyopharm is dedicated to addressing unmet medical needs through its unique approach to drug development. The company has achieved notable milestones, including regulatory approvals and partnerships that bolster its market position. Karyopharm's commitment to advancing therapeutic options underscores its role as a key player in the biopharmaceutical landscape, striving to improve patient outcomes globally.
23
DitchCarbon score
-19 vs industry average
Karyopharm Therapeutics Inc.’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Karyopharm Therapeutics Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Karyopharm Therapeutics Inc. yet.
Karyopharm Therapeutics Inc.'s reported carbon emissions
Karyopharm Therapeutics Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company.
As of now, Karyopharm has not inherited any emissions data from a parent or related organization, indicating that their climate commitments and emissions reporting are independent. Without available data or established targets, it is unclear how Karyopharm is addressing climate change or its carbon footprint within the biopharmaceutical industry context.
In summary, Karyopharm Therapeutics Inc. has yet to disclose any emissions data or climate commitments, leaving a gap in their environmental accountability.
Assessing Karyopharm Therapeutics Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Karyopharm Therapeutics Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Karyopharm Therapeutics Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Karyopharm Therapeutics Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Karyopharm Therapeutics Inc.11 months ago
23
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more